| Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial R Gold, G Giovannoni, K Selmaj, E Havrdova, X Montalban, EW Radue, ... The Lancet 381 (9884), 2167-2175, 2013 | 339 | 2013 |
| Characteristics of falling in patients with stroke C Ugur, D Gücüyener, N Uzuner, S Özkan, G Özdemir Journal of Neurology, Neurosurgery & Psychiatry 69 (5), 649-651, 2000 | 162 | 2000 |
| TÜRKİYE’DE BEYİN DAMAR HASTALIKLARI İÇİN MAJÖR RİSK FAKTÖRLERİ: TÜRK ÇOK MERKEZLİ STROK ÇALIŞMASI G Özdemir, S Özkan, N Uzuner, Ö Özdemir, D Gücüyener Türk Beyin Damar Hastalıkları Dergisi 6 (2), 31-35, 2000 | 140 | 2000 |
| Prevalence of dementia and associated risk factors in Middle Anatolia, Turkey D Arslantaş, D Özbabalık, S Metintaş, S Özkan, C Kalyoncu, G Özdemir, ... Journal of Clinical Neuroscience 16 (11), 1455-1459, 2009 | 112 | 2009 |
| Value of power Doppler and gray-scale US in the diagnosis of carpal tunnel syndrome: contribution of cross-sectional area just before the tunnel inlet as compared with the … N Akcar, S Özkan, Ö Mehmetoglu, C Calisir, B Adapinar Korean journal of radiology 11 (6), 632-639, 2010 | 106 | 2010 |
| Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer’s disease and vascular dementia S Uslu, ZE Akarkarasu, D Ozbabalik, S Ozkan, O Çolak, ES Demirkan, ... Neurochemical research 37 (7), 1554-1559, 2012 | 81 | 2012 |
| Low-level laser in the treatment of carpal tunnel syndrome: clinical, electrophysiological, and ultrasonographical evaluation F Tascioglu, NA Degirmenci, S Ozkan, O Mehmetoglu Rheumatology international 32, 409-415, 2012 | 79 | 2012 |
| Turkish standardization of movement disorders society unified Parkinson's disease rating scale and unified dyskinesia rating scale MC Akbostanci, E Bayram, V Yilmaz, S Rzayev, S Özkan, AB Tokcaer, ... Movement disorders clinical practice 5 (1), 54-59, 2018 | 51 | 2018 |
| Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment S Ozkan, DO Adapinar, NT Elmaci, D Arslantas Neuropsychiatric Disease and Treatment, 947-951, 2013 | 45 | 2013 |
| Disease-activity-free status in patients with relapsing–remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study E Havrdova, G Giovannoni, D Stefoski, S Forster, K Umans, L Mehta, ... Multiple Sclerosis Journal 20 (4), 464-470, 2014 | 33 | 2014 |
| Does radial artery harvesting for coronary revascularization cause neurological injury in the forearm and hand? M Ikizler, S Ozkan, S Dernek, C Ozdemir, OO Erdinc, B Sevin, G Ozdemir, ... European journal of cardio-thoracic surgery 28 (3), 420-424, 2005 | 31 | 2005 |
| Cerebrovascular reactivity in multiple sclerosis patients N Uzuner, S Ozkan, N Cinar Multiple Sclerosis Journal 13 (6), 737-741, 2007 | 30 | 2007 |
| Memantine improves semantic memory in patients with amnestic mild cognitive impairment: A single-photon emission computed tomography study D Ilhan Algin, S Dagli Atalay, S Ozkan, D Ozbabalik Adapinar, I Ak Sivrioz Journal of International Medical Research 45 (6), 2053-2064, 2017 | 23 | 2017 |
| Cerebral blood flow velocity changes to visual stimuli in patients with multiple sclerosis N Uzuner, S Özkan, D Gücüyener, G Özdemir Multiple Sclerosis Journal 8 (3), 217-221, 2002 | 23 | 2002 |
| Micro embolic signals in patients with cerebral ischaemic events D Gucuyener, N Uzuner, S Ozkan, O Ozdemir, G Ozdemir Neurology India 49 (3), 225-230, 2001 | 23 | 2001 |
| A case of newborn with community acquired pneumonia caused by Cupriavidus pauculus B Aydin, D Dilli, A Zenciroglu, N Okumus, S Ozkan, G Tanir Tuberk Toraks 60 (2), 160-2, 2012 | 21 | 2012 |
| An analysis of changes in cerebral blood flood velocities in depressive pseudo-dementia and Alzheimer disease patients DO Gucuyener, C Yenilmez, U Ayranci, F Ozdemir, N Uzuner, S Ozkan, ... The neurologist 16 (6), 358-363, 2010 | 21 | 2010 |
| The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis S Özkan, N Uzuner, C Kutlu, D Özbabalık, G Özdemir Journal of clinical neuroscience 13 (2), 214-217, 2006 | 21 | 2006 |
| Plasma homocysteine levels in pergolide-treated Parkinson disease patients S Özkan, Ö Colak, C Kutlu, M Ertan, Ö Alatas Clinical neuropharmacology 27 (4), 163-165, 2004 | 19 | 2004 |
| Intracerebral hemorrhage and hematoma in Behçet's disease: case report N Altinörs, E Şenveli, N Arda, A Türker, Z Kars, N Çinar, S Özkan Neurosurgery 21 (4), 582-583, 1987 | 18 | 1987 |
